Viridian Therapeutics, Inc. · NASDAQ:VRDN

Deep Track Capital, LP's stake in Viridian Therapeutics, Inc. fell to 2.65% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Deep Track Capital, LP's stake in Viridian Therapeutics, Inc. fell to 2.65%, 2,524,833 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
2.65%
Shares
2,524,833
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP2.65%2,524,833
Deep Track Biotechnology Master Fund, Ltd.2.65%2,524,833
David Kroin2.65%2,524,833

Source

View original at SEC

Related